NAMPT and neoplasm: As a possible clinical approach to make use of the increased dependence of IDH1R132H cells on NAD+ synthesis and regeneration, we examined small molecular NAMPT inhibitors FK866, GMX1778 and GNE-617, which were shown to induce cell death in a variety of tumor cells and have, in part, completed phase I trials [40].